Cite
[Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
MLA
Eising, E. G., et al. “[Somatostatin Receptor Scintigraphy in Medullary Thyroid Carcinomas, GEP and Carcinoid Tumors].” Nuklearmedizin. Nuclear Medicine, vol. 34, no. 1, Feb. 1995, pp. 1–7. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=7724358&authtype=sso&custid=ns315887.
APA
Eising, E. G., Farahati, J., Bier, D., Knust, E. J., & Reiners, C. (1995). [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors]. Nuklearmedizin. Nuclear Medicine, 34(1), 1–7.
Chicago
Eising, E G, J Farahati, D Bier, E J Knust, and C Reiners. 1995. “[Somatostatin Receptor Scintigraphy in Medullary Thyroid Carcinomas, GEP and Carcinoid Tumors].” Nuklearmedizin. Nuclear Medicine 34 (1): 1–7. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=7724358&authtype=sso&custid=ns315887.